Complement activation in patients with isolated antiphospholipid antibodies and primary antiphospholipid syndrome (PAPS)
Heparin-induced thrombocytopenia (HIT): evaluation of soluble platelet glycoprotein VI as a biomarker for HIT
Fibrinogen replacement for major haemorrhage in trauma - an in-vitro study
Management and outcomes in women with late obstetric morbidity associated with a thrombotic basis
Lupus anticoagulant guidelines: how far have these been adopted by laboratories?
Development and application of a new automated thrombin generation assay that is sensitive to activated protein C resistance
Are circulating endothelial cells increased in patients with venous thromboembolism and are levels greater in patients with underlying malignancy and venous thromboembolism?
Identification and characterization of a novel inborn error of folate metabolism causing megaloblastic anemia, pancytopenia neurodevelopmental delay and seizures
High incidence of asymptomatic osteonecrosis during treatment for childhood acute lymphoblastic leukaemia
Late cardiotoxicity in survivors of the paediatric arm of MRC AML 12
Global gene expression analysis of human erythroid progenitors
Measured levels of maternal HPA-1a antibody vary depending on the conformation and density of integrin β3
Regulation of Trib2 gene expression in normal and AML cells
Blockade of the ALK1 receptor reduces tumour microvessel density and prevents the development of osteolytic bone disease in the 5T2MM murine model of myeloma
Adult T-cell leukaemia/lymphoma (ATLL) in England 1999–2009 - use of zidovudine and interferon-alpha with chemotherapy improves survival
NCRN CLL207 study of alemtuzumab consolidation in chronic lymphocytic leukaemia: final response assessment and early follow-up (on behalf of the NCRI CLL Trials Sub-Group)
B cell-activating factor (BAFF) is elevated in acute idiopathic thrombotic thrombocytopenic purpura (TTP)
p53 is induced in human T cells during entry into the cell cycle and when bound to DNA, p53 protein complexes contain MDM2, p68-DDX5 and ΔNp73
Neonatal alloimmune thrombocytopenia (NAIT): unusual presentations and regional variations in referral
Safety of PEX in the treatment of thrombotic thrombocytopenia purpura (TTP) patients
Audit of the transfusion management of major blood loss in the emergency department of a UK teaching hospital
A multicentre prospective observational survey of the perioperative use of blood components in paediatric cardiac surgery
National comparative audit of the use of red cells in neonates and children
Frequency of red cell antibody alloimmunization in patients with sickle cell disease at Muhimbili National Hospital, Dar-es-Salaam, Tanzania
Development of an ELISA based screening test for anti-malarial antibodies
One year of real-time radiological data of venous thromboembolism (VTE) events in a large teaching hospital
CCN3 counteracts malignant features in chronic myeloid leukaemia
Over-expression of the erythropoietin receptor (EpoR) in TEL-AML1 positive acute lymphoblastic leukaemia
5-aza-2′-deoxycytidine, a DNA methylation inhibitor, induces miRNA expression changes in acute myeloid leukaemia cell lines that transcend subtype
Laser-capture micro-dissection and gene array analysis to identify new molecules implicated in the development of myeloma bone disease
The cyclin-dependent kinase inhibitor CR8 targets proliferating chronic lymphocytic leukaemia cells revealing a discrete chemo-resistant, non-dividing population
Different co-culture systems induce a similar phenotype but distinct proliferative signals in primary chronic lymphocytic leukaemia cells
Modulation of PKCα induces an upregulation of PKCβII and cyclin D1 in a chronic lymphocytic leukaemia mouse model
Gaucher derived mono-layers prime myeloma cells for survival against chemo-therapeutic agents
Video-assisted thoracoscopic (VATS) biopsy is feasible and safe in adult haemato-oncology patients undergoing stem cell transplantation or high dose chemotherapy
High C-reactive protein levels predict poor prognosis in reduced intensity conditioning allogeneic stem cell transplants
Rationalising strategies to prevent cytomegalovirus disease in recipients of T cell depleted allogeneic haemopoietic stem cell transplants (HSCT): identification of a subset of patients who reactivate but can be safely monitored
Cardiovascular risk factors in long-term survivors of stem cell transplantation for haematological malignancy
Major ABO mismatch is associated with increased non-relapse mortality in alemtuzumab-conditioned unrelated donor allogeneic haematopoietic stem cell transplantation
Therapeutic drug monitoring of itraconazole and posaconazole
Application of a new strategy to identify regulators of a signalling pathway in human immune cells
Separation of cell cycle and growth cycle programmes in primary human T cells
Final response assessment of the CLL208 trial: an open-label phase II study to investigate the safety and efficacy of rituximab plus chlorambucil in previously untreated patients with CD20-positive B-cell chronic lymphocytic leukaemia (CLL).
Outcome prediction in solitary plasmacytoma of bone: development of a risk stratification model utilising bone marrow flow cytometry and light chain analysis
The outcome for elderly patients with diffuse large B cell lymphoma achieving partial response or relapsing at least a year after first-line therapy warrants consideration of aggressive salvage
Atypical BCR-ABL1 transcript types in adult Ph-positive acute lymphoblastic leukaemia
Bendamustine, thalidomide and dexamethasone is an effective salvage regimen for advanced stage multiple myeloma
International phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom macroglobulinaemia and related disorders
Eculizumab is an effective treatment for patients with atypical hemolytic syndrome (aHUS) receiving chronic plasma therapy (PT)
Improving the immediate management of neutropenic sepsis in the United Kingdom: lessons from a national audit
Simultaneous t(5;11)(q35;p15) NUP98-NSD1 gene fusion and FLT3-itd in paediatric acute myeloid leukaemia
Treatment outcomes in a cohort of patients with Castleman's disease
Blood film examination in Malawi - the maximum diagnostic information for the least resources?
Long term treatment with eculizumab in paroxysmal nocturnal haemoglobinuria (PNH): sustained efficacy and improved survival
Paroxysmal nocturnal haemoglobinuria reveals a role for glycosylphosphatidylinositol-linked molecules in the function and peripheral homeostasis of human NK cell subsets
Low risk of stroke in children with sickle cell disease (SCD) screened with transcranial Doppler (TCD) ultrasound
Neonatal screening for haemoglobinopathies at Muhimbili National Hospital, Dar es Salaam. A pilot study
Mortality in sickle cell anaemia in Africa: rates and risk factors from a prospective cohort study in Tanzania
A haemato-neurological disease caused by mutations in SLC2A1, coding for the GLUT1 glucose transporter
Rituximab therapy for immune mediated haematological disorders: a retrospective study of the experience in Scotland on behalf of the Haematology Audit Group in Scotland (HAGIS)
Molecular analysis of putative bipotential precursors of B cells and macrophages in murine foetal liver using single-cell RT-PCR cDNA subtraction
A prospective audit of the impact of general practitioner full blood count requests on clinical haematology workload: a London teaching hospital experience
HbA2 estimations in UK National External Quality Assessment data indicate a degree of bias and the need for harmonisation of methods
An audit comparing a new intravenous (IV) iron preparation, ferric carboxymaltose (Ferinject) to IV iron dextran (Cosmofer) for the treatment of iron-deficiency anaemia in pregnancy
The use of immature platelet fraction in differentiating between aeitiologies of thrombocytopenia
An open label study for the assessment of response to oral ferrous salt supplement in the treatment of iron deficiency anemia in predominantly cereal diet based Indian patients
Dar-Oxford-London link for health: providing postgraduate haematology training (MMed and MSc in haematology)
Changes in primary care access patterns to consultant haematologist advice following the introduction of a direct GP telephone haematology advice service in a district general hospital
Raised APTT in hospitalised patients with renal impairment: causes and association with low molecular weight heparin (LMWH) in a cohort of district general hospital in-patients
Above range INR results on warfarin in a cohort of patients attending a district general hospital and review of point of care testing in response to NPSA 18
Heritability of vitamin B12 deficiency in seropositive pernicious anaemia
Chala chimodzi sichiswa nsabwe* - What use is a haematologist in Malawi?
Efficacy of low-dose rituximab for the treatment of refractory autoimmune cytopenias in adults
Retrospective audit of the initial management of neutropenic sepsis at a district general hospital
Venous thrombo-embolism prophylaxis in haematology patients
Evaluation of the completeness of national haematological malignancy registration: comparison of national data with a specialist population-based register
Thrombocytopenia in the Indian population - an interesting observation
High early mortality associated with severe anaemia in HIV positive adults in Blantyre, Malawi: is there a possibility for intervention?
In known sickle cell patients this audit investigates the time taken to administer an appropriate potent analgesic and whether, in a febrile patient (temperature > 38°C), appropriate investigations are initially carried out
Is the 2 week wait target for cancer referrals for haematology working?
Reduction in blood transfusion requirements following treatment of immune thrombocytopenic purpura with romiplostim
Digital morphology:the UK National External Quailty Assessment Scheme for General Haematology Workshop
Toxicity during induction chemotherapy for acute leukaemia - a single institute study
Improving the assessment of peripheral neuropathy in patients receiving bortezomib (velcade) treatment for multiple myeloma
Preventing venous thromboembolism: bridging the gap between theory and practice
“Don't keep me hanging on the telephone!”
Haematopoietic progenitor cell collection: smoothing the process
Fanconi's anaemia like clinical syndrome without increased chromosomal breakages
Paradoxical inhibition of the haemoglobin scavenging mechanism in sickle cell disease
Spectrum of mutations in thalassemia major and thalassemia intermedia in north Indians
Neurological events and abnormalities in SCD cohort in Tanzania
The prevalence of hypovitaminosis D in sickle cell disease
Primary care vaccination and antibiotic prophylaxis in patients with sickle cell disease: auditing NCEPOD recommendations
The haemoglobinopathy associated mutation spectrum in the North West of England - the application of a non-selective versus ethnic led analysis strategy
Use of fresh blood for transfusion of adult beta thalassaemic patients
Are shortages of O RhD negative red cells avoidable? Results of the 2010 National Comparative re-audit of the use of group O RhD negative red cells
Improving the efficient use of platelet transfusions in critically ill patients with decision support integrated into the electronic patient record
Perceived hazards of blood transfusion: can a clinician tool improve a patient's understanding?
Where are we regarding the management of major bleeding?
Introduction of patient identification guidelines and identity wristbands in Queen Elizabeth Hospital, Blantyre, Malawi
Clinical use of platelet auto-antibody testing - a prospective audit
Ferritin, serum iron levels and total iron binding capacity in the multiple transfused adult patient with sickle cell anaemia at Benin, Nigeria
Long term survival report of the UKCLL02 trial: a phase II study of subcutaneous alemtuzumab in patients with fludarabine refractory chronic lymphocytic leukaemia
The assessment of minimal residual disease in chronic lymphocytic leukaemia: comparison of multi colour flow cytometry and bone marrow trephine biopsy
The addition of cyclophosphamide to bortezomib improves response rate but not time to next treatment: five year experience of bortezomib for myeloma in a regional cancer network
Survey of breast screening in long-term survivors treated with supra-diaphragmatic irradiation for lymphoma
UK experience of Ofatumumab in refractory B-CLL
Bortezomib treatment in relapsed myeloma; effect of side effects on delivery of treatment cycles, responses and outcomes in actual clinical practice
FDG-PET/CT staging in follicular lymphoma: effect on FLIPI score
Real life experience of lenalidomide in multiple myeloma: Southwest Peninsula cancer network
Imaging in the staging of myeloma
Discharging survivors of good prognosis diffuse large B cell lymphoma
Rituximab and dexamethasone in chronic lymphatic leukaemia
Is an autologous stem cell transplant still effective salvage treatment for diffuse large B cell lymphoma in the era of upfront rituximab plus chemotherapy? An audit of outcomes from a single centre
Rate limiting steps in the process of timely lymphoma diagnosis
A 1-year experience of lymphoma diagnosis and management in rural Zambia
Reducing complication rates and increasing diagnostic yield of splenic core biopsies using fibrin glue tract sealing
Monocytoid B-cell leukaemia: a rare manifestation of probable nodal marginal zone lymphoma
Investigation of mediastinal lymphoma
R-CHOP chemotherapy is well tolerated and effective in elderly patients with diffuse large B cell lymphoma
Post transplantation lymphoproliferation disorder (PTLD) following liver transplantation: a single center experience
Prognostic significance of oligoclonal bands and excess bone marrow B lymphocytes in patients with multiple myeloma
Investigation and follow up of newly identified M-proteins - a large DGH experience
A unique case of ALK positive anaplastic large cell lymphoma initially presenting with a spontaneous leukaemic regression
Rapid diagnosis of chronic myeloid leukaemia by flow cytometric detection of BCR-ABL1 protein
Shared care protocol for the management of essential thrombocythaemia patients in primary care
Therapy related myelodysplastic syndrome and acute myeloid leukaemia (tMDS/tAML) in patients treated with purine analogues (PA) for lymphoproliferative disorders (LPD); an update
Efficient detection of Aspergillus DNA from broncho-alveolar lavage fluid of infected acute leukaemia patients
Audit of the use and response rate of bortezomib in clinical practice: a UK retrospective observational study
Evaluation of aetiology of hepatic dysfunction and its short term impact on mortality in patients of acute leukaemia during treatment.
A rare case of inherited cytopenias with dysplastic features
Oral P32 is an effective and easily administered therapy in myeloproliferative neoplasms
Chronic myeloid leukaemia (CML) audit and review of clinical experience with tyrosine kinase inhibitors (TKI) (C.A.R.C.E.T): a population based study of the management of chronic myeloid leukaemia in Leicester
Adverse effects of hydroxycarbamide are more prevalent in persons older than 60 years in essential thrombocythaemia
Late toxicity of imatinib mesylate during therapy for chronic myeloid leukaemia (CML): what happens if you stop imatinib?
Remission induction with low dose oral melphalan in acute myeloid leukemia and refractory anaemia with excess blast with normal cytogenetics and hypocellular marrow relapsing following intensive chemotherapy
All-trans retinoic acid differentiation syndrome occurring in a patient with non-promyelocytic acute myeloid leukaemia
Successful use of combination treatment with cidofovir, cytarabine and mirtazapine in a case of progressive multifocal leucoencephalopathy (PML)
Characterization of acute promyelocytic leukaemia [APML] lacking the t(15;17) with underlying PML/ RARA rearrangement
An investigation of the role of interleukin-15 in the growth and survival of pre-B acute lymphoblastic leukaemia cell lines
Homing to the central nervous system is associated with differential expression of selectins, integrins and chemokine receptors in pre-B acute lymphoblastic leukaemia cell lines
Haematopoietic stem cell kinetics in children after chemotherapy
Management of acute leukaemia relapse post paediatric allograft transplant in the last decade: a single centre experience
The spectrum and variability of the haematological phenotype of severe congenital neutropenia type 4
Cardiovascular features in severe congenital neutropenia type 4
Clinical features and outcome of paediatric thrombosis over 5 years: results from a UK regional registry
Development of a paediatric home-based bleeding score
Management of over-anticoagulation in children: a single-centre experience
A review of clostridium difficile associated diarrhoea (CDAD) in a tertiary paediatric haematology/oncology centre
Arginine to ornithine ratios in Tanzanian sickle cell anaemia patients at steady-state: a nested case control of deaths versus survivors
Brain T2-weighted signal intensity ratio in children with sickle cell disease with and without stroke
Iron status and nocturnal oximetry in Tanzanian paediatric sickle cell anaemia patients
Percutaneous endoscopic gastrostomy feeds in children with sickle cell disease and growth failure; a novel approach with high patient and carer satisfaction
Prevalence and acquired causes of anaemia in children admitted to Muhimbili National Hospital (MNH), Dar es Salaam, Tanzania
The burden and determinants of anaemia in HIV infected children attending public hospitals in Dar es Salaam
An audit of a transfusion algorithm for use in paediatric thalassaemia patients
3 year experience of deferasirox in a small paediatric cohort of beta thalassaemia major patients
Use of short term hydroxycarbamide and once weekly erythropoietin to avoid transfusion in children with sickle cell anaemia undergoing adenotonsillectomy
Treg GMP isolation for clinical trial in haematopoietic stem cell transplantation: lessons and experience
Production of TNFα discriminates activated human Th cells from Treg cells
Umbilical cord blood transplantation (UCBT) in teenagers and adults: Sheffield experience 2005–2010
Endocrine complications of stem cell transplantation for haematological malignancy
The pMHC array demonstrates that untouched T cell populations from presentation myeloid leukaemia patients can recognize multiple tumour antigens
Detailed molecular screening of an atypical CML reveals an unexpected ETV6-ABL1 fusion transcript
Risk stratification of AML patients using prognostic markers NPM1 and FLT-3 in relation to WT1 status
CD160: a novel approach to minimal residual disease (MRD) assessment in chronic lymphocytic leukaemia (CLL)
Chronic lymphocytic leukaemia lymph node T-cells show evidence of chronic antigenic stimulation
IgM ligation triggers Zeta associated protein of 70 kDa (ZAP-70) tyrosine 292 and 319 phosphorylation in B-Chronic lymphocytic leukaemia (B-CLL)
Methylseleninic acid (MSA) is an HDAC inhibitor and suppresses VEGF production in lymphoma cell lines
Effect of parthenolide on acute lymphoblastic leukaemia initiating cell populations
Evaluation of the Illumina Human CytoSNP-12 BeadChip for the detection of cytogenetic abnormalities associated with B-cell chronic lymphocytic leukaemia on archival smears, using FISH as a comparative technique
Age is associated with increased D-dimer levels, Wells score and imaging referrals in patients with suspected deep vein thrombosis
Day case surgery: who should receive pharmacological thromboprophylaxis - local practice informed by root cause analysis of hospital associated thrombosis
Cross-sectional survey of individuals with hepatitis C infection at a UK comprehensive care haemophilia centre
The impact of dabigatran on thrombin generation and other haemostatic markers after orthopaedic surgery
Mutation screening in Glanzmann thrombasthenia: identification of four novel mutations in the ITGA2B and ITGB3 genes
Protein S activity assays. Is it time for laboratories to follow national guidelines?
Thrombin generation test (TGT) in pregnant women at risk of thrombosis on LMWH (low molecular weight heparin): correlation with anti-Xa activity
Evaluation of an external quality assessment material for D-dimer point of care testing kits
Evaluation of efficacy of Orakay and Konakion in the reversal of supra-therapeutic INRs in asymptomatic patients taking warfarin therapy
Fechtner syndrome - a novel mutation
Compound heterozygosity resulting in severe factor XI deficiency
Evaluation of FVIII binding activity in type 2N von Willebrand's disease
Role of fibroscans in the non-invasive investigation of liver fibrosis in haemophiliacs with chronic hepatitis C
Applicability of BCSH guidelines for thrombophilia testing in a UK teaching hospital
Retrospective evaluation of prothrombin complex concentrate usage (Beriplex) in a one year period 2009–10
MLPA analysis in routine molecular diagnostics - a cautionary tale
Achieving best practice in venous-thromboembolism prophylaxis: the role of audit as an aid to implementation
An audit comparing standards of care for individuals with bleeding disorders in the emergency department to the UKHCDO standards
Usefulness of thromboelastography (TEG) in patients with antiphospholipid antibodies or primary antiphospholipid syndrome
The incidence of venous thromboembolism (VTE) in East London
The use of an electronic patient record to improve patient safety for anticoagulation
Evaluation of fifty patients treated with prothrombin complex concentrate
Healthcare associated venous thromboembolism: difficulties in establishing and monitoring prevalence rates
An audit of decreases in platelet counts and presence of thrombocytopaenia in patients admitted to critical care
Coagulation tests to assess bleeding risk prior to renal biopy
Lepirudin: an appropriately used safe anticoagulant in suspected heparin induced thrombocytopenia?
Outpatient warfarin loading in patients with deep vein thrombosis
From 4% to over 90%: venous thromboembolism risk assessment (VTE RA) in a district general hospital
Audit of coagulation screen requests in acute admissions at a district general hospital
Venous thrombo-embolic risk in pregnancy and the puerperium: can self-assessment identify risk and guide further care?
A comparison of the clinical utility of 2 D-dimer assays in exclusion of suspected pulmonary embolism
Access to routine dental treatment for patients with inherited bleeding disorders
High incident of pseudothrombocytopenia after cardio-pulmonary bypass
A clinical audit into the use of a new venous thromboembolism risk assessment tool in a large tertiary referral hospital in the Belfast Trust
Problems with monitoring heparin in patients with low antithrombin levels
Haemostatic and haemorheological parameters in HIV/Aids patients on antiretroviral therapy
Use of recombinant factor V11 in a district general hospital 2002–2010
Time to rein in the overuse of the ‘routine’ coagulation screen and reap the financial benefits?
Counting the cost of thrombophilia testing in a district general hospital
Implementing models of care to prevent venous thromboembolism in hospital in-patients: which is the best method?